NRIX vs PODD · rev $54.5M vs P/E 34, rev $2.07B
Nurix Therapeutics Inc (NRIX) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
NRIX currently screens at market cap $1.77B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the NRIX and PODD stock pages for the full models.
Not investment advice.